<DOC>
	<DOCNO>NCT01535508</DOCNO>
	<brief_summary>Primary : investigate tolerability interventional high dose Vitamin D3 supplementation , titrate reach serum level near high end reference range ( 30-100 ng/ml ) , vitamin D deficient pediatric Autism Spectrum Disorder ( ASD ) patient . The study determine initial safety effect estimate predict double blind randomize control trial ( RCT ) large set patient worthwhile localization treatment aim improve symptom ASDs . Exploratory : determine efficacy high dose D3 replacement improvement core symptom autism , include sociability , eye contact , anger outburst , stimming behavior , sleep , determine parental clinical evaluation scale .</brief_summary>
	<brief_title>Open Label Clinical Trial Vitamin D Children With Autism</brief_title>
	<detailed_description>data still collect</detailed_description>
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>Diagnosis Autism DSMIV TR ADOS Moderate less severe CGISeverity scale IQ &gt; 40 ZRT 25 ( OH ) D blood spot test &lt; 30 ng/ml Age 38 year old Developmental delay prior 12 month age history head trauma seizure past year bleed disorder history kidney liver disease clinically significant low white blood cell count PDDNOS , Rett 's syndrome , Childhood Disintegrative Disorder Fragile X syndrome current supplementation Vitamin D , Vitamin A codliver oil</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>8 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>